Sobi
Manufacturing · Sweden · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
Tomtebodavägen 23a, Stockholm, Stockholm...Phone Number
+46 86972000Website
www.sobi.comRevenue
$3 BillionStock Symbol
SOBIIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
6
6
1
1
1
1
About Sobi
Sobi, founded in 2010 and based in Stockholm, Sweden, is an international biopharmaceutical company. Sobi has a research focus on therapies in hematology, immunology, and more.Explore more
Sobi Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sobi your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Sobi has recently received funding, and reach out quickly before it becomes old news!
Check out if Sobi is spiking on competitors!
Earning: See what the market has to say on Sobi recently announced quarterly report
Sobi, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Sobi launches new products
Congratulate Masked Content for being promoted to Masked Content at Sobi
Click to see if Sobi had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Sobi has new funding data
Recommended Actions
Reach out to Masked Content who joined Sobi as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Sobi is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sobi is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sobi.
Sobi financials insights
Gather financial insights about Sobi, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Stock Offering
$65.4M
2016
Debt
$87.1M
Sobi Tech Stack
A closer look at the technologies used by Sobi
See more technologies
Most Recent Scoops
Hiring Plans
Sobi has more open roles in Finance than it has had at any time in the past 9 months. Areas of expertise include: Due Diligence, Business Development, Business Partnering, International Regulatory Compliance, Outsourcing, Cost Structures, and Lifecycle Management.
Hiring Plans
Hiring Plans
Sobi has more open roles in Engineering & Technical than it has had at any time in the past 12 months.
Hiring Plans
Hiring Plans
Sobi has more open roles in Information Technology than it has had at any time in the past 12 months. Technologies mentioned include: Craft.
Hiring Plans
Hiring Plans
Sobi has more open roles in Operations than it has had at any time in the past 12 months. Technologies mentioned include: Ideal, SAP, Kinaxis, 3D Hubs, Demand Planning, Kinaxis Maestro, and IFS. Areas of expertise include: Commercial Management, Cross-Functional Team Leadership, and Business Partnering.
Hiring Plans
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
Sobi News & Media
Sobi to present new data on pegcetacoplan at ERA 2026
STOCKHOLM, June 1, 2026 /PRNewswire/ -- Sobi® today announced that new data from the pegcetacoplan clinical development programme and related research in C3 glomerulopathy (C3G) and primary immune-complex membranoproliferative glomerulonephritis (IC-MPGN) will be presented at the 63rd...New analysis shows Tryngolza® (olezarsen) reduced acute pancreatitis by 85% and triglycerides by 66% in severe hypertriglyceridemia
STOCKHOLM, May 26, 2026 /PRNewswire/ -- Sobi® (STO: SOBI) today announced results from a new analysis of the pivotal Phase 3 CORE and CORE2 trials, showing Tryngolza® (olezarsen) reduced the relative risk of acute pancreatitis events by 85% (P<0.001) and reduced triglycerides by 66% in...Enable Injections Announces CE Certification of the enFuse® On-Body Delivery System for Use with Aspaveli® Distributed by Sobi
Regulatory milestone expands access to wearable, patient-centric drug delivery for rare disease treatment across Europe Regulatory milestone expands access to wearable, patient-centric drug delivery for rare disease treatment across EuropePositive topline results from the pivotal Phase 3 REDUCE 2 study of pozdeutinurad in gout
Both doses of once-daily pozdeutinurad (AR882) met the primary efficacy endpoint of sUA reduction at month 6 vs placebo Pozdeutinurad was overall well tolerated, and the safety profile was consistent with previous studies STOCKHOLM, May 21, 2026 /PRNewswire/ -- Sobi® (STO: SOBI) today...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sobi
Sign Up For FreeTo access detailed company insights
Sobi, founded in 2010 and based in Stockholm, Sweden, is an international biopharmaceutical company. Sobi has a research focus on therapies in hematology, immunology, and more.... Read More
